Brad Otto

Brad Otto is a Partner at SpringTide Ventures since May 2021, with additional roles as a Board Observer at OpenLoop, Nest Health, and WearLinq, and a Board Member at Paloma Health. Beginning in June 2023, Brad Otto also serves as an Investor at Aegle Health Partners, Leash Bio, Debut, and Sami. Prior experience includes a position as Associate at UnitedHealth Group Ventures, where Brad Otto focused on early-stage healthcare technology and co-founded Sanvello Health. Educational credentials include an MBA from Harvard University and a degree from the University of Minnesota - Carlson School of Management.